Intestinal Schistosomiasis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Intestinal Schistosomiasis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07358910

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…

Cambodia10,000 participantsStarted 2025-12-18

All recent trials (10 shown)

CompletedPhase 1/2

NCT03910972

Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults

The study will recruit up to 290 healthy adult males and non-pregnant females into a two-part clinical trial of a vaccine to protect against schistosomiasis cau…

Uganda290 participantsStarted 2019-10-07

Treatment: Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701

CompletedPhase 1

NCT03110757

A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701…

The study will be conducted as a randomized, controlled, double blind Phase 1b dose-escalating clinical trial in up to 60 healthy adult males and non-pregnant f…

Brazil60 participantsStarted 2018-05-20

Treatment: GLA-AF, Hepatitis B Virus Vaccine (Recombinant)

Intestinal Schistosomiasis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

All recent trials (10 shown)

Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults

A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

All recent trials (10 shown)

Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults

A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701…

Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)

A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Int…

Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders

Schistosoma Mansoni Morbidity in Children Aged 1-5 Years

Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis

Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal

A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes